skip to main content
Idioma:
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

Franz, David Neal, Prof ; Belousova, Elena, MD ; Sparagana, Steven, MD ; Bebin, E Martina, MD ; Frost, Michael, MD ; Kuperman, Rachel, MD ; Witt, Olaf, MD ; Kohrman, Michael H, MD ; Flamini, J Robert, MD ; Wu, Joyce Y, MD ; Curatolo, Paolo, Prof ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Thiele, Elizabeth A, MD ; Ford, James P, MS ; Shah, Gaurav, MD ; Cauwel, Helene, MSc ; Lebwohl, David, MD ; Sahmoud, Tarek, MD ; Jozwiak, Sergiusz, MD

The Lancet (British edition), 2013-01, Vol.381 (9861), p.125-132 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Emerging Treatments in the Management of Tuberous Sclerosis Complex
Emerging Treatments in the Management of Tuberous Sclerosis Complex
Material Type:
Artigo 		Adicionar ao Meu Espaço

Emerging Treatments in the Management of Tuberous Sclerosis Complex

Kohrman, Michael H., MD

Pediatric neurology, 2012-05, Vol.46 (5), p.267-275 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study
Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study

Franz, David Neal, Dr Prof ; Belousova, Elena, Prof ; Sparagana, Steven, MD ; Bebin, E Martina, MD ; Frost, Michael, MD ; Kuperman, Rachel, MD ; Witt, Olaf, Prof ; Kohrman, Michael H, Prof ; Flamini, J Robert, MD ; Wu, Joyce Y, MD ; Curatolo, Paolo, Prof ; de Vries, Petrus J, Prof ; Berkowitz, Noah, MD ; Anak, Oezlem, MD ; Niolat, Julie, MSc ; Jozwiak, Sergiusz, Prof

The lancet oncology, 2014-12, Vol.15 (13), p.1513-1520 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Idiopathic Hypersomnia
Idiopathic Hypersomnia
Material Type:
Capítulo de Livro 		Adicionar ao Meu Espaço

Idiopathic Hypersomnia

Kohrman, Michael Kryger, Meir H., MD FRCPC ; Ferber, Richard, MD ; Gozal, David, MD ; Sheldon, Stephen H., DO FAAP

Principles and Practice of Pediatric Sleep Medicine, 2014, p.153-158

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (3)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.